Surrozen (SRZN) Return on Equity [ROE] (2021 - 2025)
Surrozen (SRZN) recorded Return on Equity [ROE] of -300.23% in Q3 2025, up 123.61 percentage points from -423.84% a year earlier but down 210.10 percentage points from the prior quarter.
Powered by 
Analysis
Surrozen (SRZN) Return on Equity [ROE] (2021 - 2025) Analysis & Trends
For FY2024, Surrozen reported Return on Equity [ROE] of -288.08%, down 211.83 percentage points from FY2023.
- Annual Return on Equity [ROE] has a three-year change of -218.88 percentage points (FY2021 to FY2024).
- Across earlier years, Return on Equity [ROE] came in at -76.25% in FY2023 (-29.34 pp), -46.91% in FY2022 (+22.29 pp) and -69.20% in FY2021.
- Quarterly Return on Equity [ROE] has ranged from -423.84% in Q3 2024 to -46.54% in Q4 2021 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] rose in two of the last six quarters, with an average year-over-year change of -58.42 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 123.61 percentage points in Q3 2025, against a drop of 352.42 percentage points in Q3 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Surrozen | 384.30 Mn | -14.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -468.32% |
| Jun 30, 2025 | -177.01% |
| Sep 30, 2024 | -757.76% |
| Jun 30, 2024 | -295.34% |
| Mar 31, 2024 | -110.25% |
| Dec 31, 2023 | -102.56% |
| Sep 30, 2023 | -68.55% |
| Jun 30, 2023 | -63.23% |
| Mar 31, 2023 | -60.38% |
| Dec 31, 2022 | -47.07% |
| Sep 30, 2022 | -60.52% |
| Jun 30, 2022 | -53.36% |
| Mar 31, 2022 | -47.09% |
| Dec 31, 2021 | -46.92% |
| Sep 30, 2021 | -57.09% |
| Jun 30, 2021 | -126.33% |
API Access
Surrozen Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SRZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "SRZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SRZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();